论文部分内容阅读
目的研究新生儿溶血病的实验诊断及治疗。方法 2000年1月至2009年7月桂林市中心血站采用直接、间接抗人球蛋白法及吸收放散试验对71例新生儿溶血病患者进行实验诊断,并根据实验结果对患儿进行治疗。结果在71例新生儿溶血病患者中ABO新生儿溶血病67例,占94.36%;其中需换血治疗3例,占ABO新生儿溶血病中的4.47%;RH(D)新生儿溶血病4例,占5.64%,均行换血治疗。结论部分ABO新生儿溶血病患者需进行换血治疗,RH(D)新生儿溶血病全部需换血治疗。
Objective To study the experimental diagnosis and treatment of neonatal hemolytic disease. Methods From January 2000 to July 2009, 71 cases of hemolytic disease in newborns were diagnosed by direct and indirect antiglobulin method and absorption and desorption test in Guilin center blood bank. The treatment was performed on the basis of the experimental results. Results Among the 71 cases of hemolytic disease, 67 cases of hemolytic disease of neonatal hemolytic disease were ABO, accounting for 94.36%, of which 3 cases needed blood transfusion, accounting for 4.47% of hemolytic disease of ABO; 4 cases of RH (D) hemolytic disease , Accounting for 5.64%, are transplanting treatment. Conclusion Some ABO patients with hemolytic disease need transfusions, and all of RH (D) hemolytic disease should be transfused.